Home
Conditions
Squamous Cell Lung Cancer

Clinical trial condition

Squamous Cell Lung Cancer

Explore clinical trials studying Squamous Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

34 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Squamous Cell Lung Cancer trial results

Completed

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

NCT01948141

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

NCT01726296

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +49 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

NCT01082549

Conditions: Squamous Cell Lung Cancer
Locations: Investigational Site Number 840306 Birmingham, Alabama, United States

Investigational Site Number 840207 Huntsville, Alabama, United States

Investigational Site Number 840351 Muscle Shoals, Alabama, United States

Investigational Site Number 840338 Anaheim, California, United States

View all 142 locations

View Trial Details

Completed

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00368992

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +21 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

NCT00049543

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +22 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Lung Cancer

NCT01668823

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +17 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer

NCT00002852

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +19 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00040794

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +20 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118183

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +24 more
Locations: Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States

View Trial Details

Completed

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

NCT00087412

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +18 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Squamous Cell Lung Cancer

Squamous Cell Lung Cancer trial results

Related conditions